Well, I guess it's a challenge. If you really want a full public pharmacare program, you're talking about what you are doing about the $17 billion in private expenditure as in 2014.
I do appreciate the modellings that show that there could be some savings from bulk purchasing and so on, but that's still quite a gulp, to say the least. That's why we don't see that happening overnight in the same way that medicare came in during the sixties. It was a much smaller enterprise at the time.